Philippe Mavier
Impact in
- Hepatology top 1%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
- Hepatology 29
- Liver physiology and pathology 23
-
- Pharmacogenetics and Drug Metabolism 6
- Co-authors
- Anne-Marie PréauxDaniel DhumeauxAriane MallatJean RosenbaumÉlie Serge ZafraniYannick LapercheSylvie BlazejewskiElie‐Serge Zafrani
- Journals
- Hepatology (15 papers)Journal of Hepatology (8 papers)Biochemical Pharmacology (4 papers)Gastroenterology (3 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Philippe Mavier
65 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 109
- Hepatology 942
- Pharmacology 326
- Epidemiology 704
- Immunology 342
- Pathology and Forensic Medicine 244
Countries citing papers authored by Philippe Mavier
This map shows the geographic impact of Philippe Mavier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Mavier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Mavier more than expected).
Fields of papers citing papers by Philippe Mavier
This network shows the impact of papers produced by Philippe Mavier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Mavier. The network helps show where Philippe Mavier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philippe Mavier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 30 | |
| 2 | 2008 | 16 | |
| 3 | 2006 | 62 | |
| 4 | 2004 | 66 | |
| 5 | 2002 | 68 | |
| 6 | 1999 | 111 | |
| 7 | 1998 | 84 | |
| 8 | 1997 | 64 | |
| 9 | 1996 | 86 | |
| 10 | 1995 | 68 | |
| 11 | 1994 | 28 | |
| 12 | [Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases]. | 1993 | 34 |
| 13 | 1992 | 52 | |
| 14 | 1990 | 2 | |
| 15 | 1990 | 103 | |
| 16 | 1989 | 4 | |
| 17 | 1989 | 8 | |
| 18 | Toxicity of phorbol myristate acetate-stimulated polymorphonuclear neutrophils against rat hepatocytes. Demonstration and mechanism. | 1988 | 17 |
| 19 | 1988 | 11 | |
| 20 | [Deviation in cortisol metabolism induced by rifampicin. Therapeutic consequences in adrenal failure (author's transl)]. | 1979 | 3 |
About Philippe Mavier
Philippe Mavier is a scholar working on Hepatology, Pharmacology, Biochemistry, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 65 papers that have together received 2.3k indexed citations. Recurring topics across this work include Liver physiology and pathology (23 papers), Liver Disease Diagnosis and Treatment (11 papers), Fibroblast Growth Factor Research (7 papers), Pancreatic function and diabetes (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Alcohol Consumption and Health Effects (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Hepatology (942 citations), Pharmacology (326 citations), Epidemiology (704 citations), Immunology (342 citations) and Pathology and Forensic Medicine (244 citations). Philippe Mavier has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Anne-Marie Préaux, Daniel Dhumeaux, Ariane Mallat, Jean Rosenbaum, Élie Serge Zafrani, Yannick Laperche, Sylvie Blazejewski, Elie‐Serge Zafrani, Dominique Couchie and Nadine Martin. Their work appears in journals such as Hepatology, Journal of Hepatology, Biochemical Pharmacology, Gastroenterology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.